Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
AVDL Avadel Pharmaceuticals
- 8.100
- -0.145-1.76%
Close Feb 25 16:00 ET
780.53MMarket Cap-10.80P/E (TTM)
8.390High7.970Low1.77MVolume8.250Open8.245Pre Close14.30MTurnover2.09%Turnover RatioLossP/E (Static)96.36MShares19.09052wk High10.45P/B685.52MFloat Cap7.39052wk Low--Dividend TTM84.63MShs Float43.600Historical High--Div YieldTTM5.09%Amplitude0.710Historical Low8.098Avg Price1Lot Size
About Avadel Pharmaceuticals Company
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAVDL
Company NameAvadel Pharmaceuticals
Listing DateJun 6, 1996
Issue Price10.39
Founded2015
CEOMr. Gregory J. Divis
MarketNASDAQ
Employees154
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address10 Earlsfort Terrace
CityDublin
ProvinceDublin
CountryIreland
Zip Code02
Phone353-1-901-5201
Websitehttp://www.avadel.com
Company Executives
- Name
- Position
- Salary
- Gregory J. Divis
- Director and Chief Executive Officer
- 985.20K
- Thomas S. Mchugh
- Chief Financial Officer and Principal Accounting Officer
- 663.14K
- Scott Macke
- Vice President, Supply Chain and Operations
- --
- Geoffrey M. Glass
- Non-Executive Chairman of the Board
- 482.34K
- Linda S. Palczuk
- Independent Director
- 452.34K
- Peter J. Thornton
- Independent Director
- 459.84K
- Dr. Eric J. Ende, M.B.A.,M.D.
- Independent Director
- 452.34K
- Dr. Naseem S Amin, M.D.
- Independent Director
- --
- Dr. Mark A. Mccamish, M.D.,PhD
- Independent Director
- 449.84K
- Jerad G. Seurer
- General Counsel and Corporate Secretary
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.